查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2080349

基因組學市場：2026-2032年全球市場預測（按產品類型、技術、樣本類型、自動化程度、應用和最終用戶分類）

Genomics Market by Product Type, Technology, Sample Type, Automation Level, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，基因組學市場將成長至 1,122.6 億美元，複合年成長率為 10.12%。

主要市場統計數據
基準年 2025 571.5億美元
預計年份：2026年 626億美元
預測年份 2032 1122.6億美元
複合年成長率 (%) 10.12%

基因組學正從以研究為中心的領域轉變為精準醫療、公共衛生監測、農業生物技術、人群健康和生物製藥藥物研發的核心基礎設施。基因組學產業的發展受到定序成本持續下降、次世代定序普及、罕見疾病和腫瘤檢測中臨床效用提升以及整個醫療保健系統對高品質基因組數據日益成長的需求等因素的影響。

根據美國國家人類基因組研究所（NHGRI）發布的基準數據，自人類基因組計畫以來，DNA定序成本已大幅下降，使得20年前在商業性不可行、如今卻可應用於臨床和研究的案例成為可能。同時，英國的「十萬基因組計畫」、美國的「我們所有人」研究計畫以及亞太地區人口舉措等國家級計畫正在加速建構支持診斷、治療和預防醫學的參考資料集。

對產業領導者而言，基因組學格局不再僅僅取決於定序處理能力。競爭優勢越來越依賴整合的工作流程，這些工作流程結合了檢體製備、定序化學、生物資訊學、變異解讀、安全的雲端基礎設施、符合監管要求的數據管治以及臨床決策支援。

基因組學領域的變革性變化

隨著定序工作從集中式研究機構轉向臨床路徑、分散式檢查模式和人群規模項目，基因組學格局正在經歷結構性變革。腫瘤學仍然是臨床應用的主要領域，這主要得益於伴隨診斷、腫瘤譜分析、液態生物檢體的發展以及基於可操作基因組突變的治療選擇。

人工智慧對基因組學的累積影響

人工智慧正以前所未有的速度推動基因組學領域的發展，顯著提升了變異識別、註釋、表現型匹配、蛋白質結構預測、藥物標靶優先排序和臨床試驗設計等方面的能力。深度學習模型提高了序列比對、結構變異檢測和複雜基因組訊號解讀的準確性，而人工智慧驅動的知識圖譜則為變異與疾病機制和治療假設的關聯提供了有力支持。

基因組學方面的關鍵區域見解

亞太地區是基因組學領域發展最快的地區之一，這得益於大規模的人群樣本、不斷提升的定序能力以及各國政府對精準醫療的大力支持。中國正大力投資定序基礎設施和人群規模的研究，而印度的「印度基因組舉措」（GenomeIndia）和蓬勃發展的生物技術產業正在加強本地參考資料集的建設。日本、韓國、新加坡和澳洲則透過全國性的研究網路、癌症基因組學計畫以及醫院合作定序舉措，持續推動臨床基因組學的發展。

基因組學方面的關鍵小組見解

隨著東協成員國加大對精準醫療、感染疾病監測和生物醫學檢查室網路和定序能力。

主要國家基因組學發展趨勢

美國憑藉著強大的風險投資、先進的診斷檢測實驗室、美國國立衛生研究院（NIH）資助的研究以及廣泛的腫瘤定序，引領全球基因組學的商業化進程。加拿大正透過省級計畫和學術網路推動精準醫療的發展，而墨西哥則致力於提升公共衛生基因組學、癌症診斷和跨境研究的能力。巴西憑藉其學術定序網路、感染疾病監測經驗以及不斷拓展的精準腫瘤學活動，在拉丁美洲的基因組學領域處於領先地位。

為基因組學領域的領導者提供的實用建議

產業領導者應優先考慮經臨床檢驗的應用案例，即基因組檢測能夠實際改善診斷、治療選擇或病患管理的案例。腫瘤學、罕見病學、生殖醫學、藥物基因組學和感染疾病監測等領域，若能結合明確的證據生成和與保險公司的合作，便可帶來顯著的短期機會。

調查方法

本執行摘要基於系統的二手研究方法，使用了檢驗的公共資訊來源、監管文件、同行評審文獻、國家基因組學研究途徑的最新資訊、公共衛生機構資料以及行業報告資訊。引用的資訊來源包括美國國家人類基因組研究所 (NHGRI)、美國國立衛生研究院 (NIH)、世界衛生組織 (WHO)、美國食品藥物管理局(FDA)、歐盟委員會、英國基因組學中心以及各國精準醫療計畫等機構。

結論

基因組學正進入一個新階段，其特徵是與臨床實踐的整合、人工智慧驅動的解讀、群體規模數據的生成以及多體學的融合。該領域最大的機會在於那些能夠展現臨床效用、減少醫療保健不確定性並支持標靶治療決策的應用。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 基因組學市場：依產品類型分類

  • 定序平台
    • 次世代定序（NGS）平台
    • Sanger/毛細管定序平台
  • 試劑和耗材
    • 酵素和母料
    • 樣品製備工具包
    • 探針和引子
  • 軟體和分析
    • 基因表現分析
    • 變異檢測與註釋工具
  • 服務
    • 基因組檢測服務
    • 基因型鑒定和SNP分析
    • 轉錄組學和表觀基因學服務

第8章：基因體學市場：依技術分類

  • 陣列技術
    • 利用微陣列進行基因表現分析
    • SNP基因型鑒定晶片
  • PCR技術
  • DNA定序
  • RNA定序
    • 批量RNA定序
    • 單細胞RNA定序

第9章 基因組學市場：依樣本類型分類

  • 血
  • 組織
  • 唾液和口腔黏膜拭子
  • 培養細胞

第10章 基因組學市場：依自動化程度分類

  • 手動的
  • 半自動
  • 全自動

第11章 基因組學市場：依應用分類

  • 農業
    • 動物基因體學
    • 作物基因組學
  • 診斷
    • 癌症基因體學
    • 基因檢測
    • 傳染病檢查
  • 藥物發現與開發
    • 生物標記發現
    • 目標識別
  • 個人化醫療
    • 伴隨診斷
    • 精準治療

第12章 基因組學市場：依最終用戶分類

  • 學術機構及政府機構
  • 私人研究機構
  • 醫院和診所
  • 製藥和生物技術公司

第13章 基因組學市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章 基因組學市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 基因組學市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • 10x Genomics, Inc.
  • 23andMe Holding Co.
  • Agilent Technologies, Inc.
  • BGI Genomics Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • Centogene NV
  • Danaher Corporation
  • EPIC Sciences, Inc.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • Gencove, Inc.
  • GenScript Biotech Corporation
  • Guardant Health, Inc.
  • Helix OpCo, LLC
  • Illumina, Inc.
  • Invitae Corporation
  • Merck & Co., Inc.
  • Myriad Genetics Laboratories, Inc.
  • Natera, Inc.
  • Oxford Nanopore Technologies PLC
  • Pacific Biosciences of California, Inc.
  • Personalis, Inc.
  • Quest Diagnostics
  • SomaLogic, Inc.
  • Sophia Genetics SA
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation
Product Code: MRR-434CCDA04CD1

The Genomics Market is projected to grow by USD 112.26 billion at a CAGR of 10.12% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 57.15 billion
Estimated Year [2026] USD 62.60 billion
Forecast Year [2032] USD 112.26 billion
CAGR (%) 10.12%

Genomics is moving from a research-intensive discipline into a core infrastructure layer for precision medicine, public health surveillance, agricultural biotechnology, population health, and biopharmaceutical discovery. The genomics industry is being shaped by sustained reductions in sequencing costs, broader access to next-generation sequencing, expanding clinical utility for rare disease and oncology testing, and rising demand for high-quality genomic data across healthcare systems.

Publicly available benchmarks from the National Human Genome Research Institute show that DNA sequencing costs have fallen dramatically since the Human Genome Project, enabling clinical and research use cases that were not commercially practical two decades ago. At the same time, national programs such as the United Kingdom's 100,000 Genomes Project, the U.S. All of Us Research Program, and population genomics initiatives in Asia-Pacific are accelerating the creation of reference datasets that support diagnostics, therapeutics, and preventive care.

For industry leaders, the genomics landscape is no longer defined only by sequencing throughput. Competitive advantage increasingly depends on integrated workflows that combine sample preparation, sequencing chemistry, bioinformatics, variant interpretation, secure cloud infrastructure, regulatory-grade data governance, and clinical decision support.

Transformative Shifts in the Genomics Landscape

The genomics landscape is undergoing a structural shift as sequencing migrates from centralized research laboratories into clinical pathways, decentralized testing models, and population-scale programs. Oncology remains a leading area of clinical adoption, supported by companion diagnostics, tumor profiling, liquid biopsy development, and therapy selection based on actionable genomic variants.

Rare disease diagnostics are also transforming care delivery. Whole-exome and whole-genome sequencing have shortened diagnostic odysseys for patients with suspected genetic disorders, while newborn sequencing pilots are evaluating how genomic screening can complement traditional metabolic screening. These applications are increasing demand for validated interpretation pipelines, genetic counseling capacity, and reimbursement models tied to clinical utility.

Another major shift is the convergence of genomics with multiomics. Organizations are integrating genomics with transcriptomics, proteomics, metabolomics, epigenomics, and real-world clinical data to improve disease stratification and biomarker discovery. This transition is expanding the value chain from sequencing instruments and consumables toward analytics platforms, cloud-native data architecture, and evidence-generation services.

Cumulative Impact of Artificial Intelligence on Genomics

Artificial intelligence is becoming a major force multiplier in genomics by improving variant calling, annotation, phenotype matching, protein structure prediction, drug target prioritization, and clinical trial design. Deep learning models have improved accuracy in sequence alignment, structural variant detection, and interpretation of complex genomic signals, while AI-enabled knowledge graphs help connect variants to disease mechanisms and therapeutic hypotheses.

The cumulative impact is especially visible in drug discovery and precision medicine. AI can reduce manual review burdens, identify patient subgroups, and support biomarker-driven development programs. The success of computational biology tools, including AI-based protein structure prediction, has strengthened confidence in data-driven life sciences research and accelerated investment in genomics-enabled discovery platforms.

However, the adoption of AI in genomics depends on data quality, transparency, bias mitigation, explainability, and regulatory alignment. Models trained on underrepresented populations can produce inequitable performance, making diverse reference datasets and rigorous validation essential. Organizations that combine AI capability with compliant data governance and clinically validated workflows are better positioned to scale genomic medicine responsibly.

Key Regional Insights for Genomics

Asia-Pacific is one of the fastest-developing genomics regions due to large population cohorts, expanding sequencing capacity, and strong government interest in precision medicine. China has invested heavily in sequencing infrastructure and population-scale research, while India's GenomeIndia initiative and growing biotechnology sector are strengthening local reference datasets. Japan, South Korea, Singapore, and Australia continue to advance clinical genomics through national research networks, cancer genomics programs, and hospital-linked sequencing initiatives.

North America remains a global leader because of its dense ecosystem of academic medical centers, biotechnology firms, diagnostic laboratories, cloud providers, and regulatory experience. The United States benefits from NIH-backed programs, FDA engagement on diagnostics and companion tests, and large-scale precision medicine adoption in oncology and rare disease. Canada contributes through provincial genomics networks, public health genomics, and population health research.

Europe is characterized by coordinated public investment, strong data protection standards, and cross-border genomics collaboration. The European Union's 1+ Million Genomes initiative and national programs in the United Kingdom, Germany, France, Italy, and Spain support clinical implementation and interoperable data frameworks. Latin America is gaining momentum through cancer genomics, infectious disease surveillance, and academic partnerships, with Brazil and Mexico playing important roles. The Middle East is advancing through national genome programs in Gulf countries, while Africa is becoming increasingly important for human genetic diversity research, pathogen genomics, and equitable reference dataset development.

Key Group Insights for Genomics

ASEAN is emerging as a strategically important genomics group because member states are investing in precision health, infectious disease surveillance, and biomedical research capacity. Singapore acts as a regional genomics hub with advanced infrastructure, while Thailand, Malaysia, Indonesia, Vietnam, and the Philippines are expanding laboratory networks and public health sequencing capabilities.

The GCC is accelerating genomics through national genome programs, population screening, and precision medicine investments, particularly in the United Arab Emirates, Saudi Arabia, and Qatar. These initiatives are supported by high digital health investment and a policy focus on inherited disease, preventive care, and localized reference genomes. The European Union is advancing a coordinated genomics model through common data standards, privacy frameworks, and cross-border research programs that aim to make genomic data more interoperable for healthcare and innovation.

BRICS countries represent a large share of the world's population and are increasingly relevant for diverse genomic datasets, domestic sequencing capacity, and cost-sensitive diagnostics. G7 countries continue to lead in regulatory science, clinical research, reimbursement policy, and advanced biopharmaceutical applications. NATO countries add relevance through biosecurity, pathogen surveillance, and resilience planning, where genomic epidemiology supports early detection and response to biological threats.

Key Country Insights for Genomics

The United States leads global genomics commercialization through strong venture investment, advanced diagnostic laboratories, NIH-funded research, and widespread oncology sequencing. Canada is advancing precision health through provincial programs and academic networks, while Mexico is building capacity in public health genomics, cancer diagnostics, and cross-border research. Brazil anchors Latin American genomics with academic sequencing networks, infectious disease surveillance experience, and growing precision oncology activity.

In Europe, the United Kingdom remains highly influential through Genomics England, NHS genomic medicine infrastructure, and the legacy of the 100,000 Genomes Project. Germany is strengthening clinical genomics through university hospitals and national genomics initiatives, France is advancing genomic medicine through its national healthcare strategy, and Italy and Spain are expanding cancer genomics, rare disease sequencing, and biobank-linked research. Russia maintains capabilities in biomedical research and population genetics, although international collaboration dynamics are shaped by geopolitical constraints.

In Asia-Pacific, China has developed large-scale sequencing capacity, domestic instrument and service provider ecosystems, and extensive population research. India is expanding its genomics base through GenomeIndia, a large patient population, and growth in affordable diagnostics. Japan emphasizes clinical quality, cancer research, and aging-related genomics, while Australia combines strong research universities with national genomics networks and rare disease initiatives. South Korea is advancing precision medicine through hospital-based sequencing, digital health infrastructure, and biotechnology investment.

Actionable Recommendations for Genomics Leaders

Industry leaders should prioritize clinically validated use cases where genomic testing demonstrably improves diagnosis, treatment selection, or patient management. Oncology, rare disease, reproductive health, pharmacogenomics, and infectious disease surveillance offer strong near-term opportunities when paired with clear evidence generation and payer engagement.

Organizations should invest in end-to-end workflow integration rather than isolated sequencing capacity. Scalable advantage comes from connecting sample logistics, automation, sequencing, bioinformatics, interpretation, reporting, genetic counseling, and longitudinal data capture. Partnerships with hospitals, reference laboratories, cloud infrastructure providers, and biopharmaceutical organizations can accelerate adoption while reducing implementation friction.

Data governance must be treated as a strategic capability. Leaders should build privacy-preserving architectures, ensure consent traceability, improve ancestry diversity in datasets, and validate AI models across populations. Organizations that align with regulatory expectations, reimbursement requirements, and clinical quality standards will be better positioned to earn trust and expand adoption of genomic medicine.

Research Methodology

This executive summary is based on a structured secondary research approach using verified public sources, regulatory references, peer-reviewed literature, national genomics program updates, public health agency materials, and industry-reported information. Sources considered include organizations such as the National Human Genome Research Institute, National Institutes of Health, World Health Organization, U.S. Food and Drug Administration, European Commission, Genomics England, and national precision medicine programs.

The analysis applies triangulation across technology trends, clinical adoption patterns, regional policy initiatives, funding signals, and ecosystem developments. Insights were evaluated for relevance to sequencing technologies, diagnostics, bioinformatics, AI-enabled genomics, population genomics, and clinical implementation.

The synthesis emphasizes data-backed interpretation without relying on unsupported claims. The methodology prioritizes verifiable evidence, cross-source validation, and practical implications for executive decision-making across healthcare, biotechnology, diagnostics, and life sciences.

Conclusion

Genomics is entering a new phase defined by clinical integration, AI-enabled interpretation, population-scale data generation, and multiomics convergence. The sector's strongest opportunities are linked to applications that prove clinical utility, reduce healthcare uncertainty, and support targeted treatment decisions.

Regional momentum is broadening beyond traditional innovation centers as Asia-Pacific, the Middle East, Latin America, and Africa invest in genomic infrastructure and localized reference datasets. At the same time, North America and Europe continue to shape regulatory models, clinical standards, and commercialization pathways.

Organizations that combine scientific rigor, scalable data systems, equitable datasets, responsible AI, and strong clinical partnerships will be best positioned to lead in the next generation of genomic medicine.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Genomics Market, by Product Type

  • 7.1. Sequencing Platforms
    • 7.1.1. Next-Generation Sequencing (NGS) Platforms
    • 7.1.2. Sanger / Capillary Sequencing Platforms
  • 7.2. Reagents & Consumables
    • 7.2.1. Enzymes & Master Mixes
    • 7.2.2. Library Preparation Kits
    • 7.2.3. Probes & Primers
  • 7.3. Software & Analytics
    • 7.3.1. Gene Expression Analysis
    • 7.3.2. Variant Calling & Annotation Tools
  • 7.4. Services
    • 7.4.1. Genomic Testing Services
    • 7.4.2. Genotyping & SNP Analysis
    • 7.4.3. Transcriptomics & Epigenomics Services

8. Genomics Market, by Technology

  • 8.1. Array Technology
    • 8.1.1. Microarray Gene Expression
    • 8.1.2. SNP Genotyping Arrays
  • 8.2. PCR Technology
  • 8.3. DNA Sequencing
  • 8.4. RNA Sequencing
    • 8.4.1. Bulk RNA Sequencing
    • 8.4.2. Single-Cell RNA Sequencing

9. Genomics Market, by Sample Type

  • 9.1. Blood
  • 9.2. Tissue
  • 9.3. Saliva & Buccal Swabs
  • 9.4. Cultured Cells

10. Genomics Market, by Automation Level

  • 10.1. Manual
  • 10.2. Semi-Automated
  • 10.3. Fully Automated

11. Genomics Market, by Application

  • 11.1. Agriculture
    • 11.1.1. Animal Genomics
    • 11.1.2. Crop Genomics
  • 11.2. Diagnostics
    • 11.2.1. Cancer Genomics
    • 11.2.2. Genetic Testing
    • 11.2.3. Infectious Disease Testing
  • 11.3. Drug Discovery & Development
    • 11.3.1. Biomarker Discovery
    • 11.3.2. Target Identification
  • 11.4. Personalized Medicine
    • 11.4.1. Companion Diagnostics
    • 11.4.2. Precision Therapeutics

12. Genomics Market, by End User

  • 12.1. Academic & Government Institutes
  • 12.2. Commercial Research Organizations
  • 12.3. Hospitals & Clinics
  • 12.4. Pharmaceutical & Biotechnology Companies

13. Genomics Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Genomics Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Genomics Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. 10x Genomics, Inc.
  • 17.2. 23andMe Holding Co.
  • 17.3. Agilent Technologies, Inc.
  • 17.4. BGI Genomics Co., Ltd.
  • 17.5. Bio-Rad Laboratories, Inc.
  • 17.6. Centogene N.V.
  • 17.7. Danaher Corporation
  • 17.8. EPIC Sciences, Inc.
  • 17.9. Eurofins Scientific SE
  • 17.10. F. Hoffmann-La Roche Ltd.
  • 17.11. Gencove, Inc.
  • 17.12. GenScript Biotech Corporation
  • 17.13. Guardant Health, Inc.
  • 17.14. Helix OpCo, LLC
  • 17.15. Illumina, Inc.
  • 17.16. Invitae Corporation
  • 17.17. Merck & Co., Inc.
  • 17.18. Myriad Genetics Laboratories, Inc.
  • 17.19. Natera, Inc.
  • 17.20. Oxford Nanopore Technologies PLC
  • 17.21. Pacific Biosciences of California, Inc.
  • 17.22. Personalis, Inc.
  • 17.23. Quest Diagnostics
  • 17.24. SomaLogic, Inc.
  • 17.25. Sophia Genetics SA
  • 17.26. Thermo Fisher Scientific Inc.
  • 17.27. Twist Bioscience Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL GENOMICS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL GENOMICS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL GENOMICS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL GENOMICS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL GENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL GENOMICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL GENOMICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL GENOMICS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL GENOMICS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL GENOMICS MARKET SIZE, BY AUTOMATION LEVEL, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL GENOMICS MARKET SIZE, BY AUTOMATION LEVEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL GENOMICS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL GENOMICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL GENOMICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL GENOMICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL GENOMICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL GENOMICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL GENOMICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL GENOMICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL GENOMICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL GENOMICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL GENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SEQUENCING PLATFORMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SEQUENCING PLATFORMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SEQUENCING PLATFORMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NEXT-GENERATION SEQUENCING (NGS) PLATFORMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NEXT-GENERATION SEQUENCING (NGS) PLATFORMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NEXT-GENERATION SEQUENCING (NGS) PLATFORMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SANGER / CAPILLARY SEQUENCING PLATFORMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SANGER / CAPILLARY SEQUENCING PLATFORMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SANGER / CAPILLARY SEQUENCING PLATFORMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENZYMES & MASTER MIXES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ENZYMES & MASTER MIXES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENZYMES & MASTER MIXES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL LIBRARY PREPARATION KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL LIBRARY PREPARATION KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL LIBRARY PREPARATION KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PROBES & PRIMERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PROBES & PRIMERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PROBES & PRIMERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SOFTWARE & ANALYTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SOFTWARE & ANALYTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SOFTWARE & ANALYTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL VARIANT CALLING & ANNOTATION TOOLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL VARIANT CALLING & ANNOTATION TOOLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL VARIANT CALLING & ANNOTATION TOOLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL GENOMIC TESTING SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL GENOMIC TESTING SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL GENOMIC TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GENOTYPING & SNP ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GENOTYPING & SNP ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GENOTYPING & SNP ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL TRANSCRIPTOMICS & EPIGENOMICS SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL TRANSCRIPTOMICS & EPIGENOMICS SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL TRANSCRIPTOMICS & EPIGENOMICS SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ARRAY TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ARRAY TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ARRAY TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MICROARRAY GENE EXPRESSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MICROARRAY GENE EXPRESSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MICROARRAY GENE EXPRESSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SNP GENOTYPING ARRAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SNP GENOTYPING ARRAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SNP GENOTYPING ARRAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PCR TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PCR TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PCR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL DNA SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DNA SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DNA SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL RNA SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL RNA SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL RNA SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BULK RNA SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BULK RNA SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BULK RNA SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SINGLE-CELL RNA SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SINGLE-CELL RNA SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SINGLE-CELL RNA SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL GENOMICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BLOOD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BLOOD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BLOOD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL TISSUE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL TISSUE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL TISSUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SALIVA & BUCCAL SWABS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SALIVA & BUCCAL SWABS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SALIVA & BUCCAL SWABS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CULTURED CELLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CULTURED CELLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CULTURED CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL GENOMICS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MANUAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MANUAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MANUAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SEMI-AUTOMATED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SEMI-AUTOMATED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SEMI-AUTOMATED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL FULLY AUTOMATED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL FULLY AUTOMATED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL FULLY AUTOMATED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL AGRICULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL AGRICULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL AGRICULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ANIMAL GENOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ANIMAL GENOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ANIMAL GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL CROP GENOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL CROP GENOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL CROP GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL CANCER GENOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL CANCER GENOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL CANCER GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL GENETIC TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL BIOMARKER DISCOVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL BIOMARKER DISCOVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL BIOMARKER DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL TARGET IDENTIFICATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL TARGET IDENTIFICATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL TARGET IDENTIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL PRECISION THERAPEUTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL PRECISION THERAPEUTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL PRECISION THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL GENOMICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ACADEMIC & GOVERNMENT INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL ACADEMIC & GOVERNMENT INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL ACADEMIC & GOVERNMENT INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL COMMERCIAL RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL COMMERCIAL RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL COMMERCIAL RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL GENOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC GENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC GENOMICS MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC GENOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC GENOMICS MARKET SIZE, BY SOFTWARE & ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC GENOMICS MARKET SIZE, BY ARRAY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC GENOMICS MARKET SIZE, BY RNA SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC GENOMICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC GENOMICS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC GENOMICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC GENOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC GENOMICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA GENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA GENOMICS MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA GENOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA GENOMICS MARKET SIZE, BY SOFTWARE & ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA GENOMICS MARKET SIZE, BY ARRAY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA GENOMICS MARKET SIZE, BY RNA SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA GENOMICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA GENOMICS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA GENOMICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA GENOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 180. NORTH AMERICA GENOMICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA GENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA GENOMICS MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA GENOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA GENOMICS MARKET SIZE, BY SOFTWARE & ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA GENOMICS MARKET SIZE, BY ARRAY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA GENOMICS MARKET SIZE, BY RNA SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA GENOMICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA GENOMICS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 194. LATIN AMERICA GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA GENOMICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 196. LATIN AMERICA GENOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA GENOMICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE GENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE GENOMICS MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE GENOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE GENOMICS MARKET SIZE, BY SOFTWARE & ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE GENOMICS MARKET SIZE, BY ARRAY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE GENOMICS MARKET SIZE, BY RNA SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE GENOMICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE GENOMICS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE GENOMICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE GENOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE GENOMICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST GENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST GENOMICS MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST GENOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST GENOMICS MARKET SIZE, BY SOFTWARE & ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST GENOMICS MARKET SIZE, BY ARRAY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST GENOMICS MARKET SIZE, BY RNA SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 224. MIDDLE EAST GENOMICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST GENOMICS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 226. MIDDLE EAST GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 228. MIDDLE EAST GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST GENOMICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 230. MIDDLE EAST GENOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST GENOMICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA GENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA GENOMICS MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA GENOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA GENOMICS MARKET SIZE, BY SOFTWARE & ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 237. AFRICA GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 238. AFRICA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 239. AFRICA GENOMICS MARKET SIZE, BY ARRAY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 240. AFRICA GENOMICS MARKET SIZE, BY RNA SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 241. AFRICA GENOMICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. AFRICA GENOMICS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 243. AFRICA GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. AFRICA GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 245. AFRICA GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 246. AFRICA GENOMICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 247. AFRICA GENOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 248. AFRICA GENOMICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 249. GLOBAL GENOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN GENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN GENOMICS MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN GENOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN GENOMICS MARKET SIZE, BY SOFTWARE & ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN GENOMICS MARKET SIZE, BY ARRAY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN GENOMICS MARKET SIZE, BY RNA SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN GENOMICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN GENOMICS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 262. ASEAN GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 263. ASEAN GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 264. ASEAN GENOMICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 265. ASEAN GENOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 266. ASEAN GENOMICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. GCC GENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 268. GCC GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. GCC GENOMICS MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 270. GCC GENOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 271. GCC GENOMICS MARKET SIZE, BY SOFTWARE & ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 272. GCC GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 273. GCC GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 274. GCC GENOMICS MARKET SIZE, BY ARRAY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 275. GCC GENOMICS MARKET SIZE, BY RNA SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 276. GCC GENOMICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. GCC GENOMICS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 278. GCC GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 279. GCC GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 280. GCC GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 281. GCC GENOMICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 282. GCC GENOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 283. GCC GENOMICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPEAN UNION GENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPEAN UNION GENOMICS MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION GENOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPEAN UNION GENOMICS MARKET SIZE, BY SOFTWARE & ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPEAN UNION GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION GENOMICS MARKET SIZE, BY ARRAY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPEAN UNION GENOMICS MARKET SIZE, BY RNA SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION GENOMICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 294. EUROPEAN UNION GENOMICS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 295. EUROPEAN UNION GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 296. EUROPEAN UNION GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 297. EUROPEAN UNION GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 298. EUROPEAN UNION GENOMICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 299. EUROPEAN UNION GENOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 300. EUROPEAN UNION GENOMICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 301. BRICS GENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 302. BRICS GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 303. BRICS GENOMICS MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 304. BRICS GENOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 305. BRICS GENOMICS MARKET SIZE, BY SOFTWARE & ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 306. BRICS GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 307. BRICS GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 308. BRICS GENOMICS MARKET SIZE, BY ARRAY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 309. BRICS GENOMICS MARKET SIZE, BY RNA SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 310. BRICS GENOMICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 311. BRICS GENOMICS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 312. BRICS GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 313. BRICS GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 314. BRICS GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 315. BRICS GENOMICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 316. BRICS GENOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 317. BRICS GENOMICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 318. G7 GENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 319. G7 GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 320. G7 GENOMICS MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 321. G7 GENOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 322. G7 GENOMICS MARKET SIZE, BY SOFTWARE & ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 323. G7 GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 324. G7 GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 325. G7 GENOMICS MARKET SIZE, BY ARRAY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 326. G7 GENOMICS MARKET SIZE, BY RNA SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 327. G7 GENOMICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 328. G7 GENOMICS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 329. G7 GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 330. G7 GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 331. G7 GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 332. G7 GENOMICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 333. G7 GENOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 334. G7 GENOMICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 335. NATO GENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 336. NATO GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 337. NATO GENOMICS MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 338. NATO GENOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 339. NATO GENOMICS MARKET SIZE, BY SOFTWARE & ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 340. NATO GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 341. NATO GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 342. NATO GENOMICS MARKET SIZE, BY ARRAY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 343. NATO GENOMICS MARKET SIZE, BY RNA SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 344. NATO GENOMICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 345. NATO GENOMICS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 346. NATO GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 347. NATO GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 348. NATO GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 349. NATO GENOMICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 350. NATO GENOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 351. NATO GENOMICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 352. GLOBAL GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 353. UNITED STATES GENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 354. UNITED STATES GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 355. UNITED STATES GENOMICS MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 356. UNITED STATES GENOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 357. UNITED STATES GENOMICS MARKET SIZE, BY SOFTWARE & ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 358. UNITED STATES GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 359. UNITED STATES GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 360. UNITED STATES GENOMICS MARKET SIZE, BY ARRAY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 361. UNITED STATES GENOMICS MARKET SIZE, BY RNA SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 362. UNITED STATES GENOMICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 363. UNITED STATES GENOMICS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 364. UNITED STATES GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 365. UNITED STATES GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 366. UNITED STATES GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 367. UNITED STATES GENOMICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 368. UNITED STATES GENOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 369. UNITED STATES GENOMICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 370. CANADA GENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 371. CANADA GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 372. CANADA GENOMICS MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 373. CANADA GENOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 374. CANADA GENOMICS MARKET SIZE, BY SOFTWARE & ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 375. CANADA GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 376. CANADA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 377. CANADA GENOMICS MARKET SIZE, BY ARRAY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 378. CANADA GENOMICS MARKET SIZE, BY RNA SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 379. CANADA GENOMICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 380. CANADA GENOMICS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 381. CANADA GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 382. CANADA GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 383. CANADA GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 384. CANADA GENOMICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 201